Table 1.
Characteristic | Overall |
---|---|
| |
Age, median (IQR) | 57(47, 64) |
| |
Male gender N (%) | 72 (67) |
| |
Previously healthy N (%) | 21 (20) |
| |
APACHE1 II Score median (IQR) | 21(18,23) |
| |
CPC2 prior to arrest | |
1 N (%) | 101 (95) |
2 N (%) | 6 (5) |
| |
Cardiac Arrest Site | |
Out-of-hospital N (%) | 82 (77) |
| |
Witnessed Arrest N (%) | 92 (86) |
| |
Bystander CPR3 N (%) | 73 (63) |
| |
Initial Rhythm | |
VT4/VF5, N(%) | 85 (79) |
| |
STEMI6, N(%) | 32 (30) |
| |
Intra-Aortic Balloon Pump N(%) | 17 (16) |
| |
Shock N (%) | 46 (44) |
| |
Coronary angiography performed N (%) | 83 (78) |
| |
Percutaneous Coronary Intervention N (%) | (36) |
| |
Temporary Pacemaker | 5 (6) |
| |
Fentanyl, Median total dose in mg during ICU stay( IQR) N7 = 90 | 2700 (1569, 4444) |
| |
Midazolam, Median total dose in mg during ICU stay (IQR) N7 = 72 | 64 (40, 108) |
| |
Propofol, Median total dose in mcg during ICU stay (IQR) N7 = 26 | 1198 (295, 1663) |
Acute Physiology and Chronic Health Evaluation
Cerebral Performance Score
Cardiopulmonary resuscitation
Ventricular tachycardia
Ventricular fibrillation
ST segment elevation myocardial infarction
Median for drug doses is only for those patients that received actual drug